Evidence map›Paper›PMID 16052034›Full record

ArticleNucleic acids research2005

FAST DB: a website resource for the study of the expression regulation of human gene products.

Pierre de la Grange, Martin Dutertre, Natalia Martin, Didier Auboeuf

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 90 citations in OpenAlex.

  1. Article
  2. An impaired splicing program underlies differentiation defects in hSOD1Cellular and molecular life sciences : CMLS · 2023
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. TwoGenes · 2021
    Article
  8. Article
  9. Article
  10. Prognostic impact of cancer stem cell markersAmerican journal of translational research · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors.Clinical cancer research : an official journal of the American Association for Cancer Research · 2017
    Article
  16. p27Oncogene · 2017
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Pierre de la GrangeINSERM U685/AVENIR, Centre G. Hayem, Institut Universitaire d'Hématologiem, Hôpital Saint Louis, 1 Avenue Claude Vellefaux, 75010 Paris, France.
Martin Dutertre
Natalia Martin
Didier Auboeuf
Hôpital Saint-Louis · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human genes use various mechanisms to generate different transcripts having different exon content, which in turn generate multiple protein isoforms having differential and even opposite biological activities. To understand the biological consequences of gene transcriptional activity modulation, it is necessary to integrate the capability of genes to generate distinct functional products, particularly because transcriptional stimuli also affect the exon content of their target gene products. For this purpose, we have developed a bioinformatics suite, FAST DB, which defines easily and accurately the exon content of all known transcripts produced by human genes. In addition, several tools have been developed, including a graphical presentation of all gene products, a sequence multi-alignment of all gene transcripts and an in silico PCR computer program. The FAST DB interface also offers extensive links to website resources for promoter analysis and transcription factor binding site prediction, splicing regulatory sequence prediction, as well as 5'- and 3'-untranslated region analysis. FAST DB has been designed to facilitate studies that integrate transcriptional and post-transcriptional events to investigate the expression regulation of human gene products.

Indexed as

Alternative SplicingDatabases, Nucleic AcidExonsGene Expression RegulationSoftwareComputational BiologyComputer GraphicsDNA, ComplementaryDNA PrimersExpressed Sequence TagsHumansInternetPolymerase Chain ReactionRNA, MessengerSequence AlignmentSequence Analysis, RNADNA, ComplementaryDNA PrimersRNA, Messenger

Identifiers

PMID16052034
PMCPMC1181862
OpenAlexW2107881499

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.